Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Bernadette, Foran"'
Autor:
David J. Thomson, Clare Cruickshank, Helen Baines, Russell Banner, Matthew Beasley, Guy Betts, Helen Bulbeck, Frances Charlwood, Judith Christian, Matthew Clarke, Olly Donnelly, Bernadette Foran, Callum Gillies, Clare Griffin, Jarrod J. Homer, Johannes A. Langendijk, Lip Wai Lee, James Lester, Matthew Lowe, Andrew McPartlin, Elizabeth Miles, Christopher Nutting, Nachi Palaniappan, Robin Prestwich, James M. Price, Clare Roberts, Justin Roe, Ramkumar Shanmugasundaram, Rita Simões, Anna Thompson, Catharine West, Lorna Wilson, Jane Wolstenholme, Emma Hall
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 38, Iss , Pp 147-154 (2023)
Externí odkaz:
https://doaj.org/article/efbbc2d562cf40079af68d82a83fc6b6
Publikováno v:
Care of Head and Neck Cancer Patients for Dental Hygienists and Dental Therapists. :116-122
Publikováno v:
Care of Head and Neck Cancer Patients for Dental Hygienists and Dental Therapists. :107-115
Autor:
Dorothy M. Gujral, Kevin J. Harrington, Win Soe, Aisha Miah, M. Emson, David Bernstein, Katie Wood, James P Morden, Amen Sibtain, Matthew Beasley, Deborah Gardiner, Nachi Palaniappan, Audrey Cook, Teresa Guerrero Urbano, Shelia Fisher, Tom Roques, M. Rizwanullah, Mehmet Sen, Paul Sanghera, Emma Hall, Christopher D Scrase, Vivian P Cosgrove, Christopher M. Nutting, Clare Griffin, Shanmugasundaram Ramkumar, Elizabeth Junor, Shreerang Bhide, Catherine M West, Bernadette Foran, Hisham Mehanna
Publikováno v:
European Journal of Cancer. 153:242-256
Background Radical (chemo)radiotherapy offers potentially curative treatment for patients with locally advanced laryngeal or hypopharyngeal cancer. We aimed to show that dose-escalated intensity-modulated radiotherapy (DE-IMRT) improved locoregional
Autor:
T. Roques, T. Fulton-Lieuw, M. Vreugdenhil, Paul Sanghera, Bernadette Foran, Mehmet Sen, Hisham Mehanna, M. Evans, Charles Fong, Christopher M. Nutting, M. Dalby, Gulnaz Iqbal, Andrew Hartley, H. Yang, H. Al Booz, L. O'Toole, N. Palaniappan, Janet A. Dunn
Publikováno v:
Clinical oncology (Royal College of Radiologists (Great Britain)). 33(12)
AIMS The De-ESCALaTE study showed an overall survival advantage for the administration of synchronous cisplatin chemotherapy with radiotherapy in low-risk oropharyngeal cancer when compared with synchronous cetuximab. During the trial, a radiotherapy
Autor:
Carol MacGregor, Danny Dubois, Sharon Forsyth, Krystyna Reczko, Fiona McKinna, Allan Hackshaw, Jason F. Lester, Vivek Misra, Tim Sevitt, Noelle O'Rourke, Krishnaswamy Madhavan, Andrew Bates, Bernadette Foran, Rhona McMenemin, Andre Lopes, Sharon Shibu Thomas, Tanya Holt, Peter Hoskin, Daniel Roos, Sanjay Dixit, Gillian Brown, Sandy Beare, Kirsten Hopkins, Seonaid Arnott
Publikováno v:
Hoskin, P J, Hopkins, K, Misra, V, Holt, T, McMenemin, R, Dubois, D, McKinna, F, Foran, B, Madhavan, K, MacGregor, C, Bates, A, O'Rourke, N, Lester, J F, Sevitt, T, Roos, D, Dixit, S, Brown, G, Arnott, S, Thomas, S S, Forsyth, S, Beare, S, Reczko, K, Hackshaw, A & Lopes, A 2020, ' Effect of Single-Fraction vs Multifraction Radiotherapy on Ambulatory Status Among Patients With Spinal Canal Compression From Metastatic Cancer : The SCORAD Randomized Clinical Trial ', JAMA, vol. 322, no. 21, pp. 2084-2094 . https://doi.org/10.1001/jama.2019.17913
JAMA
JAMA
Importance: Malignant spinal canal compression, a major complication of metastatic cancer, is managed with radiotherapy to maintain mobility and relieve pain, although there is no standard radiotherapy regimen.Objective: To evaluate whether single-fr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8eeeb94343472f17f4699dda852515bd
https://pure.manchester.ac.uk/ws/files/158972081/01_SCORAD_draft_txt_04_10_2019.docx
https://pure.manchester.ac.uk/ws/files/158972081/01_SCORAD_draft_txt_04_10_2019.docx
Autor:
Graham M. Wheeler, Martin Forster, K. Blair, A. Chandrakumar, V. Spanswick, Y. Pathak, Paul Gougis, Sharon Forsyth, Bernadette Foran, K. Yip, H. Lowe, Laura White, J. Hartley
Publikováno v:
Annals of Oncology. 31:S686-S687
Autor:
Nicholas J Slevin, Mehmet Sen, David J Thomson, Lynne Dixon, Finbar Slevin, Robin Prestwich, Hitesh Mistry, Shermaine Pan, Bernadette Foran
Publikováno v:
Clinical oncology (Royal College of Radiologists (Great Britain)). 32(4)
Aims To report the outcomes of nasopharyngeal carcinoma in adults across three large centres in a non-endemic region in the era of intensity-modulated radiotherapy (IMRT). Materials and methods Adult patients with nasopharyngeal carcinoma treated in
Autor:
Hisham, Mehanna, Max, Robinson, Andrew, Hartley, Anthony, Kong, Bernadette, Foran, Tessa, Fulton-Lieuw, Matthew, Dalby, Pankaj, Mistry, Mehmet, Sen, Lorcan, O'Toole, Hoda, Al Booz, Karen, Dyker, Rafael, Moleron, Stephen, Whitaker, Sinead, Brennan, Audrey, Cook, Matthew, Griffin, Eleanor, Aynsley, Martin, Rolles, Emma, De Winton, Andrew, Chan, Devraj, Srinivasan, Ioanna, Nixon, Joanne, Grumett, C René, Leemans, Jan, Buter, Julia, Henderson, Kevin, Harrington, Christopher, McConkey, Alastair, Gray, Janet, Dunn, Mererid, Evans
Background The incidence of human papillomavirus (HPV)-positive oropharyngeal cancer, a disease affecting younger patients, is rapidly increasing. Cetuximab, an epidermal growth factor receptor inhibitor, has been proposed for treatment de-escalation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::8f9a742f7f62a9c70dd5f401210c7ca7
https://strathprints.strath.ac.uk/75921/1/Mehanna_etal_TL_2018_Radiotherapy_plus_cisplatin_or_cetuximab_in_low_risk_human_papillomavirus_positive_oropharyngeal_cancer.pdf
https://strathprints.strath.ac.uk/75921/1/Mehanna_etal_TL_2018_Radiotherapy_plus_cisplatin_or_cetuximab_in_low_risk_human_papillomavirus_positive_oropharyngeal_cancer.pdf
Publikováno v:
The Journal of Laryngology and Otology
JOURNAL OF LARYNGOLOGY AND OTOLOGY
JOURNAL OF LARYNGOLOGY AND OTOLOGY
This is the official guideline endorsed by the specialty associations involved in the care of head and neck cancer patients in the UK. Significantly new data have been published on laryngeal cancer management since the last edition of the guidelines.